Showing results (451-460 of 491) with videos related to
Sort By:
Pageof 50
Biorxiv : the Preprint Server for Biology|July 10, 2026
Multimodal Human Scalp Atlas Defines Cell Landscape and Lineage Architecture In SituEdward B Li, Christopher M Stephens, Meredith Klay, et al.International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiformeAimee L Quan, Gene H Barnett, Shih-Yuan Lee, et al.American Journal of Physical Anthropology|June 23, 1999
Multiple origins of the mtDNA 9-bp deletion in populations of South IndiaW S Watkins, M Bamshad, M E Dixon, et al.Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.Bioorganic & Medicinal Chemistry Letters|January 27, 2010
Phenyltriazolinones as potent factor Xa inhibitorsMimi L Quan, Donald J P Pinto, Karen A Rossi, et al.Cell Death & Disease|May 6, 2016
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathwaysT T Zhou, L L Quan, L P Chen, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitorsJ V Duncia, J B Santella, C A Higley, et al.The American Journal of Dermatopathology|January 31, 2020
Retrospective Cohort: Genomic Differences Between Pigmented Spindle Cell Nevi of Reed and Reed-Like MelanomasLauren S Mohan, Ayesha U Khan, Bin Zhang, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Nonbenzamidine tetrazole derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2013
Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigenSoung-Chul Cha, Hong Qin, Shibichakravarthy Kannan, et al.Pageof 50